BKLSX | GARIX | BKLSX / GARIX | |
Total Expense Ratio | 1.56 | 1.50 | 104% |
Annual Report Gross Expense Ratio | 2.84 | 1.72 | 165% |
Fund Existence | 2 years | 13 years | - |
Gain YTD | 2.972 | 6.310 | 47% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 100000 | 5,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12M | 822M | 1% |
Annual Yield % from dividends | 9.57 | 0.00 | - |
Returns for 1 year | -5.27 | -5.31 | 99% |
Returns for 3 years | N/A | 25.43 | - |
Returns for 5 years | N/A | 53.61 | - |
Returns for 10 years | N/A | 58.70 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BRXCX | 14.98 | -0.17 | -1.12% |
MFS Blended Research Intl Eq C | |||
UEMPX | 8.42 | -0.11 | -1.29% |
UBS Emerging Markets Equity Opp P | |||
REREX | 57.41 | -0.78 | -1.34% |
American Funds EUPAC R4 | |||
FMGGX | 48.34 | -0.67 | -1.37% |
Franklin Small-Mid Cap Growth R6 | |||
CEFIX | 13.16 | -0.20 | -1.50% |
Calvert Emerging Markets Advancement I |